Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

7th Aug 2007 16:30

7 August 2007

Shire plc (the "Company")

Notification of the Exercise of an Option and Sale of Shares by a Person Discharging Managerial Responsibilities

The Company was notified by Ms Anita Graham, Executive Vice President, Corporate Business Services and Chief Administrative Officer on 6 August 2007, of the exercise in London on the same day, of an option over 25,000 ordinary 5p shares in the capital of the Company at an exercise price of ‚£5.26. Ms Graham chose to use a net settled cashless exercise facility run by the Company which resulted in a total of 14,395 shares being allotted to her. The option over the remaining 10,605 shares lapsed.

The Company was further notified, by Ms Graham, on 6 August 2007, of the sale in London on the same day of 14,395 ordinary 5p shares in the capital of the Company at a price of ‚£12.40.

Following this transaction Ms Graham retains share options and stock appreciation rights over a total of 355,133 ordinary shares in the Company.

T May

Company Secretary

For further information please contact:

Investor Relations Clĩa Rosenfeld (Rest of the World) +44 1256 894 160 Eric Rojas (North America) +1 484 595 8252 Notes to editorsSHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company's website: www.shire.com.

Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release

Registered in England 5492592Registered Office as above

SHIRE PLC

Related Shares:

Shire
FTSE 100 Latest
Value8,774.65
Change-17.15